Novo Nordisk’s next obesity battlefront: Winning beyond America

Novo Nordisk's weight loss pill had a strong launch in the U.S. and is expected to replicate this success in other global markets. The company is confident about its performance beyond America. This indicates a positive outlook for Novo Nordisk's obesity treatment.